Influence of cyclic AMP on facial nerve regeneration in rats by Borin, Andrei et al.
675
Brazilian Journal of otorhinolaryngology 74 (5) SeptemBer/octoBer 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
Influence of cyclic AMP on 
facial nerve regeneration in rats
   Summary
Andrei Borin1, Ronaldo Nunes Toledo2, Paulo Lee 
Ho3, José Ricardo Gurgel Testa4, Oswaldo Laércio 
Mendonça Cruz5, Yotaka Fukuda6 
1 Master’s degree in otorhinolaryngology; doctoral student.
2 Biologist and doctorate in biochemistry; researcher at the Centro de Biotecnologia, Instituto Butantan.
3 Doctorate in otorhinolaryngology, adjunct professor, otorhinolaryngology discipline, UNIFESP/EPM.
4 Livre-docente (habilitation) professor, affiliated professor, otorhinolaryngology discipline, UNIFESP/EPM.
5 Livre-docente (habilitation) professor, otorhinolaryngology discipline, UNIFESP/EPM.
Otorhinolaryngology and Head & Neck Department, Universidade Federal de Sao Paulo.
Address for correspondence: Andrei Borin Rua Loefgreen 1587 apto 152 Sao Paulo SP 04040-032.
E-mail: andreiborin@hotmail.com
This paper was submitted to the RBORL-SGP (Publishing Manager System) on 18 April 2007. Code 4460.
The article was accepted on 4 August 2007.
Promoting facial nerve regeneration is a significant 
challenge. Aim: To evaluate the possible neurotrophic 
influence of cyclic AMP on facial nerve regeneration of Wistar 
rats. Method: The right facial nerve of thirty-two animals were 
completely transected and immediately sutured, followed 
by exposure or not to topical cyclic AMP. Behavioral and 
histometric analyses were done at 14 and 28 days. Results: 
Statistical differences (p<0.05) were found in the behavioral 
and histometric analyses on the 14th day, suggesting an early 
regenerative response of the facial nerve to cAMP exposure. 
Conclusion: This study demonstrates a possible neurotrophic 
effect of cAMP on facial nerve regeneration in rats.
Keywords: cyclic amp, histology, facial nerve, rat, nerve 
regeneration.
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INTRODUCTION
In the well-known human anatomy book by Gard-
ner/Gray/O’Rahilly, facial mimicry is described as being 
done by 22 muscle groups derived from the second bran-
chial arch.1 These muscles are innervated by the motor 
division of the 7th (facial) cranial nerve. Injury to this 
nerve results in multiple dysfunctions that have cosmetic, 
functional and psychological impacts on such patients.2-4
The first attempts to optimize the regeneration of 
sutured nerves, using topical sulphonamide in the injury 
site, were undertaken in the Second World War.5 In 1951, 
Levi-Montalcini and Hamburger6 noticed that some tumors 
induced marked peripheral nerve growth, and suggested 
that these tumors probably produced endogenous subs-
tances that yielded this effect. Since then, controlled nerve 
injury has been used in experiments to study the effect of 
various physical, chemical and biological factors on nerve 
regeneration. In 1994, Heifti defined neurotrophic factors 
as those proteins that were able to regulate nerve cell 
survival and differentiation, nervous system development 
and integrity, and neuronal plasticity.7 This definition is 
currently being extended, since not only proteins have 
these actions, and since these factors have other properties, 
such as stimulating nerve growth and branching, inducing 
neuronal anabolism and modulating neurotransmission 
and electrical conductivity.8
Adenosine cyclic monophosphate (cAMP), which 
consists of adenylate cyclase and is degraded by phos-
phodiesterase, may be found in all eukaryotic cells;9 it 
is currently considered the main intracellular messenger 
molecule for a variety of cell stimuli.9,10 Since 1955, rese-
arch on the effect of glucagon on liver cells was started,11 
cAMP has been held responsible for diverse events, such 
as controlling heart tone and inotropism,12 ovarian cell 
maturation and adrenal cell endocrine secretion.9 This mo-
lecule has also been associated with tumor cell resistance 
or susceptibility to chemotherapy,13-15 suggesting promising 
possibilities in cancer therapy. The herb Coleus forskohlii 
is used in traditional Hindu culture for treating insomnia, 
seizures and heart conditions; it contains the alkaloid for-
skolin, which raises the level of adenylate cyclase.16
A number of studies have clarified the role of camp 
in the neurological system. Clinically, it is involved in tu-
mor growth, such as in astrocytomas, ependymomas and 
pituitary adenomas,17 and in neuronal protein expression 
in Alzheimer’s disease18 patients, among other effects. 
Results of cell culture studies showing that cAMP affects 
the survival and neuronal differentiation of PC 12 cells19-
22 and myelin production by Schwann cells23,24 suggests 
that this nucleotide appears to have a neurotrophic role. 
Interneuronal synapse production25 and glial cell activity 
levels26 appear to be additional effects of cAMP. In ani-
mals, it seems to be associated with neuronal resistance to 
hypoxia in turtles during prolonged dives27 and with the 
extreme regenerative abilities of the spinal cord in fish.28 
Sciatic nerve recovery in rats was tested in the 1970s, with 
conflicting results.29,30 New promising results in sciatic 
nerve recovery were published in the 1980s.31,32 However, 
we found no published paper on the role of cAMP in 
mammal facial nerve regeneration; this then became our 
theme for study.
METHOD
The Research Ethics Committee at our institution 
approved this research project (number 1708/05). Male 
Wistar rats weighing between 200 and 240 g, kept in 
adequate cages in a climatized room under a 12-hour day-
night cycle and with free access to water and food, were 
used in this study. There were four animal experiment 
groups, as follows: “cAMP 14D”: complete transection of 
the right facial nerve trunk, followed by prompt suturing 
and exposure of the injury site to cAMP and sacrifice 14 
days later; “CTRL 14D”: the same injury and suture with 
exposure to Ringer’s lactate (RL) and sacrifice 14 days later; 
“cAMP 28D”: the same injury and suture with exposure 
to cAMP and sacrifice 28 days later; and “CTRL 28D”: the 
same injury and suture with exposure to RL and sacrifice 
28 days later. The initial procedure for right facial nerve 
trunk transection and suturing was done in accordance 
with the established description for an experimental mo-
del by our group.33 Osmotic pumps (Alzet® Mini-osmotic 
Pump model 2002) coupled to a polyethylene catheter 
flowing at 0.5μl/hour for 14 days was used for releasing 
cAMP into the neural suture site. These pumps were 
placed subcutaneously in the interscapular region during 
the first procedure; the catheter tip was fixed in place 
with prolene 7-0 sutures at about 2mm from the neural 
suture. A solution containing dibutyril-cAMP 1mM salt 
manufactured by Sigma® (“N6,2´-O-dibutiryladenosine 
3´:5´-cyclic monophosphate”) diluted in RL was used in 
groups exposed to cAMP. Pumps contained only RL in 
the other groups.
Animals underwent behavioral observation of 
facial mimicry in alternate days after surgery until 14 or 
28 days, depending on the group, to observe vibrissal 
movement and closure of the palpebral rima. Scores for 
these observations have been described by Borin et al.;33 
each item is scored 0 to 5 points, noting the progression 
of movement recovery.
The animals were sacrificed after 14 or 28 days, and 
the right facial nerve was dissected to locate the suture line 
and to remove a distal fragment for histological analysis. 
The contralateral facial nerve trunk (left) was also removed 
from all rats and sent for histological analysis. Biopsy ma-
terial for histology and the digitized microscopy images of 
the facial nerve were processed in the Electron Microscopy 
Center (Centro de Microscopia Eletrônica - CEME) at our 
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institution, according to a previously described protocol.33 
Pictures were displayed sequentially according to the time 
between injury and sacrifice and exposure or not to cAMP 
for qualitative histological analysis; the presence of myeli-
nated fibers, their relative diameter and the uniformity of 
their distribution within the nerve were noted. Myelinated 
fibers in right and left facial nerve trunks in each rat were 
counted33 and the right/left ratio was obtained for the 
quantitative histological analysis (histometry). The area 
studied in each nerve was 6399.679μm2.
The statistical analysis of data was based on two 
associated events: intervention (drug - administration or 
not of cAMP) and time (14 or 28 days). Data from each 
group were analyzed as follows: 
1) clinical score for vibrissal movement; 
2) clinical score for closure of palpebral rima; 
3) fiber count in the left facial nerve; 
4) fiber count in the right facial nerve; 
5) right-left fiber count ratio. The analysis of varian-
ce (ANOVA) test was used for the comparative analysis to 
detect possible differences among group means, followed 
by a POST-HOC test. The significance level was 5%.
RESULTS
The first procedure was done in 32 animals, eight 
in each experimental group. One week after surgery we 
noticed a soft tumor that had formed around the osmotic 
pump in one of the animals in the cAMP group; this animal 
was sacrificed, and the finding was an encapsulated inflam-
matory process containing pus. We discarded this animal 
from the sample and operated another rat for the 8-animal 
group. Thus, 33 animals were used in this study.
After performing euthanasia we had a subjective 
impression that there was more fibrosis in the dissection 
of the right facial nerve trunk in the animals belonging to 
the groups cAMP 14D and cAMP 28D. Furthermore, their 
nerves were apparently thicker (increased diameter); these 
subjective impressions were written in the observation 
sheets. We found no difficulties in locating the site of 
the epineural suture done in the first procedure; a distal 
segment was removed in all animals.
 
Behavioral Observation
We found improved vibrissal movement and closu-
re of the palpebral rima in all groups. The mean clinical 
scores (and standard deviations) are presented in Table 
1;,Graphs 1 and 2 show the confidence interval of the 
analysis. We also found that regardless of exposure to 
cAMP, animals sacrificed in the 28th day had better results 
compared to those sacrificed in the 14th day. The cAMP 
14D group had superior results compared to the CTRL 
14D group in closure of the palpebral rima, but not in 
vibrissal movement.
Table 1. Clinical score (mean (standard deviation)).
cAMP 14D CTRL 14D cAMP 28D CTRL 28D
Vibrissal
movement 
0,946 0,750 1,241 1,321
(0,264) (0,148) (0,235) (0,273)
Closure of 
palpebral rima
1,768 1,089 2,295 2,143
(0,540) (0,295) (0,436) (0,589)
Graph 1. Clinical scores for palpebral rima closure. Confidence interval 
for the mean: mean ± 1.96 * standard deviation / √ (n-1)
Graph 2. Clinical scores for vibrissal movement. Confidence interval 
for the mean: mean ± 1.96 * standard deviation / √ (n-1)
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Qualitative Histological Analysis
We obtained 64 images of the right and left facial 
nerves of each of the eight animals in each group. Images 
of the left facial nerve (not injured) in all animals showed 
no differences; their myelinated fibers were evenly distri-
buted throughout all images, as shown in Fig. 1.
The right facial nerves in groups cAMP 28D and 
CTRL 28D had more of these small myelinated ungrouped 
fibers, although there were variations between animals. 
There were also fibers of a larger diameter that were more 
similar to the left facial nerve. Figs. 4 and 5 show each of 
these groups.
Figure 1. Typical aspect of the left facial nerve (UNINJURED) in all 
groups.
Images of the right facial nerves in groups CTRL 14D 
and cAMP 14D (injured nerves) showed small myelinated 
fibers with a lower diameter compared to the correspon-
ding contralateral images; these fibers were often grouped 
rather than evenly distributed throughout the field. These 
findings appeared somewhat more evident in some animals 
compared to others; they were also more evident in group 
cAMP 14D compared to the group CTRL 14D. Figs. 2 and 
3 show these results.
Figure 2. Typical aspect of the right facial nerve in the AMPc 14D group. 
Arrowhead shows clusters of small myelinated fibers
Figure 3. Typical aspect of the right facial nerve in the CTRL 14D group. 
Arrowhead shows clusters of small myelinated fibers
Figure 4. Typical aspect of the right facial nerve in the AMPc 28D group. 
Arrowhead shows larger diameter myelinated fiber
 
Quantitative Histological Analysis (Histometry)
Fiber count means (and standard deviations) in left 
and right facial nerves and the right/left ratio are shown 
on Table 2; a comparative analysis is shown on Graphs 3 
and 5. The left facial nerve (not injured) count did not vary 
among the four groups. The right facial nerve (injured) 
count, and the right/left ratio was higher on the 28th day 
compared to the 14th day, regardless of the presence of 
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cAMP, suggesting that regeneration occurred along those 
periods. After 14 days the drug concentration was higher in 
the cAMP 14D group (32.6 ±24.2) compared to the group 
CTRL 14D (9.4 ±11.5); the right/left ratio was 31% x 9.7%. 
After 28 days, the drug concentration was higher in the 
CTRL 28D group (123.2 ±16.8) compared to the cAMP 28D 
group (92.1 ±13.0).
Figure 5. Typical aspect of the right facial nerve in the CTRL 28D 
group
Table 2. Myelinated fiber count (mean (standard deviation)).
cAMP 14D CTRL 14D cAMP 28D CTRL 28D
Left facial 
nerve
110,375 104,750 110,125 98,625
(23,360) (19,667) (11,457) (14,232)
Right facial 
nerve
32,625 9,375 92,125 123,250
(24,160) (11,488) (13,021) (16,816)
Right/left ratio 
(%)
30,603 9,695 84,590 127,531
(24,090) (11,913) (15,472) (26,981)
Graph 3. Fiber count in the left facial nerve. Confidence interval for the 
mean: mean ± 1.96 * standard deviation / √ (n-1)
Graph 4. Fiber count in the right facial nerve. Confidence interval for 
the mean: mean ± 1.96 * standard deviation / √ (n-1)
Graph 5. Right/left ratio - fiber count. Confidence interval for the mean: 
mean ± 1.96 * standard deviation / √ (n-1)
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DISCUSSION
In 1972, Appenzeller and Palmer34 found that cAMP 
levels were increased in regenerating nerves. Since then 
various authors have raised the possibility that cAMP might 
have a neurotropic role; this has been further tested expe-
rimentally “in vitro” (cell cultures).23-25 Studies on the effect 
of cAMP on sciatic nerve regeneration in rodents have 
yielded variable results, with nerve stimulation in some29,31 
and absence of stimulation in others.30,35 Much of this 
apparent conflict may be explained by the methods. The 
model we used in this paper (sciatic nerve crush injury) 
does not, in our view, cause homogeneous injury; crushing 
time ranged from 2 to 30 seconds, and the pressure was 
not measured. The time elapsed before analysis of results 
also varied in these papers; positive results were found in 
studies by Pichero et al.29 and Gershenbaum and Roisen31 
after the 12th day, while studies by McQuarrie et al.30 and 
Black and Lasek35 were ended earlier (9 and 8 days) and 
therefore revealed no neurotrophic effects.
In 1984, Kilmer and Carlsen36 applied topical for-
skolin, which raises the levels of adenylate cyclase, thus 
increasing endogenous cAMP, achieving positive results 
in sciatic nerve regeneration in frogs. In 1987, these au-
thors suggested delivering cAMP in pellets into the nerve 
injury site of hamster sciatic nerves, and found promising 
results.32 Studies on the role of exogenous cAMP should 
assure that this substance truly penetrates de cell for its in-
tracellular action, as there are no extracellular receptors for 
this substance.37 The analogues dibutyril-cAMP and 8-bro-
mo-cAMP pass through the plasmatic membrane and are 
less susceptible to phosphodiesterase action; their effect, 
therefore, is more evident than that of natural cAMP.13,38 We 
believe the topical route is preferable for growth factors; 
if eventually it becomes used in humans, the dose and 
side effects would be lower compared to systemic use.4 
Additionally, neurotrophic factors affect other cell groups, 
which in theory might stimulate tumor growth elsewhere 
when used systemically; a similar conundrum is estrogen 
hormone replacement therapy in patients with a family 
history of breast cancer. Another advantage of topical use 
is that the contralateral nerve may be used as a control for 
the injured nerve in experimental studies.4,39
In our method we decided to transect completely 
and suture the nerve since this is a more reproducible 
injury; it is always classified as grade V (Suderland);39,40 it 
also best reproduces the surgical correction of nerve injury 
in human beings.41 We also chose to deliver dibutyril-cAMP 
topically for the reasons given above. We also chose to 
extend our investigation to 28 days for increased reliabi-
lity and to add behavioral and histological evaluations for 
increased objectivity. A deeper debate about our method 
may be found in Borin et al.33 We understand that our 
type of suture is more an approximation of neural stump 
rather than a classical microsurgical suture, since it was 
technically impossible to place more than one suture stitch 
in the facial nerve of rats.
Our behavioral analysis showed recovery of func-
tion accelerated by cAMP when tested by closure of the 
palpebral rima, but not by vibrissal movement, in the 14th 
day; this effect was not seen in animals tested after the 28th 
day. This finding has been reported by other authors, who 
have stated that the earliest sign of recovery of the facial 
nerve in rodents is partial recovery of the blink reflex.42 
Komura et al. (1999)4 investigated the regenerating effect 
of the brain-derived neurotropic factor (BDNF) in the rat 
facial nerve, and found similar results, with earlier clinical 
recovery within the first 14 days and loss of accelerated 
recovery after 23 days. It appears to us that cAMP may 
stimulate early recovery, but not the end functional results; 
we discuss this further when commenting our histological 
findings. It is clear that the analysis of facial mimicry in 
rats is limited in that it does not allow any perception of 
nuances in expression compared to the scales used in 
human beings. Thus we lose the ability to detect subtle 
differences in motor recovery of the rat face at more ad-
vanced recovery stages.
We might find it curious that the animals in this 
study had facial movements so soon. Our methodologi-
cal pilot study33 had already detected that about 35% of 
facial function returned within three weeks and 60% in 
five weeks. Komura et al.4 noted early recovery (14 days) 
following complete transection and suture of facial ner-
ves in rats; Gershbaum and Roisen31 were surprised with 
the fact that the rat sciatic nerve showed clinical activity 
within two to three weeks of injury. This could be due 
to different crossed innervation compared to human ana-
tomy, which is reflected in the activity of the contralateral 
facial nerve, as some authors have suggested,43-45 and/or 
a higher regeneration rate in rat compared to humans, as 
other authors have suggested.31
Fiber count of the left facial nerve (not injured) did 
not vary significantly among groups in this study. This 
finding confirms not only the findings that describe the 
lack of variability of this inter-species criterion, even when 
weight and age are different,46 but also the possibility of 
using samples of the non-injured size as controls for the 
injured side in neural regeneration experiments.39,47,48 Data 
showed a significantly increased myelinated fiber count 
in the right facial nerve (injured side) on the 14th day in 
the cAMP group compared to controls, a finding that was 
confirmed by the right/left ratio analysis. Apparently, cAMP 
stimulated early neural regeneration, accelerating axonal 
sprouting from the proximal stump. More fibers were 
found and our qualitative histological findings showed fine 
fibers grouped in blocks, which may mean a cross-section 
of neural sprouting, composed of the small immature 
fibers described by other authors.30,49-51 Using electron mi-
681
Brazilian Journal of otorhinolaryngology 74 (5) SeptemBer/octoBer 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
croscopy, Gershenbaum and Roisen31 showed that cAMP 
accelerated the onset of Wallerian degeneration on the 3rd 
day after injury in the rat sciatic nerve model; there were 
also more fibers on the 10th day in the group exposed to 
cAMP, compared to the group exposed to saline.
Various authors have suggested numerous mecha-
nisms by which topical and systemic cAMP might stimulate 
neural regeneration, although many doubts remain.31,32 
Genic expression effects14,27 and cytoskelelal changes36,38 
in a variety of cell groups involved in neural regeneration 
have already been demonstrated. It is thought that cAMP 
may stimulate neuronal populations and also support 
structures, such as microglia, macrophages and Schwann 
cells.23-26 It would thus “clean up” the injury site, remo-
ving cell remains, accelerating Wallerian degeneration, 
myelination and the neuronal growth sprout by acting on 
the neuron cell nucleus and/or the injury site.31,32,34,36 Our 
study did not include the investigation of the mechanism 
of action of cAMP, so we accept these hypotheses.
On the 28th day we found an inversion in the 
previous hystometric finding, in which the fiber count in 
the control group and in contralateral nerves (right/left 
ratio = 127%) was higher than that in the group exposed 
to cAMP. There are a few possibilities for explaining this 
apparently conflicting result. In our experiment, the os-
motic pump delivered cAMP only during the first 14 days; 
the remaining two weeks were nucleotide-free. This could 
suggest that nucleotide action might take place only if it is 
present, and that initially hyperstimulated fibers would be 
eventually lost. Furthermore, other authors have suggested 
that sprouting is stimulated by local factors such as cAMP, 
while neurite outgrowth depends on metabolic changes in 
the neuronal nuclear body, and therefore topical delivery 
would lose its effect with time.32 Concerning the higher 
fiber count in the right side compared to the left side in 
the CTRL 28D group, McQuarrie et al.30 found that after 
unilateral sciatic nerve injury, the number of fibers in the 
injured site was 40% higher compared to the uninjured 
side; these authors suggested that multiple sprouting from 
a single axon in the proximal stump might cause these 
findings. Byers et al.52 have described similar findings in 
a study of rat facial nerve regeneration.
In cell cultures, neurotrophic factors may induce 
cell differentiation and phenotypical changes, followed by 
decreased cell numbers. For instance, in cells originating 
from neuroblastomas, cAMP increases differentiation by 
stimulating new dendrites, at the same time decreasing 
the total number of cells.53 In our studies we probably 
witnessed early axonal sprouting and a decreased total 
number of regenerating fibers as a secondary effect. If 
so, the final functional results would not be altered, as 
the behavioral analyses in groups cAMP 28D and CTRL 
28D were similar.
A further explanation is that during regeneration, 
the many fibers present initially in sprouting are gradually 
selected as “winners,” their diameter and myelination is 
increased to strengthen conduction, and inefficient fibers 
are lost.31,41,48-51 Komura et al. 19994 analyzed neural rege-
neration by expression of GAP43 protein mRNA, which 
affects axonal outgrowth. These authors found more signi-
ficant clinical recovery in the BDNF-exposed group in the 
14th day, followed by increased GAP43 protein mRNA; in 
the 28th day, behavioral findings were similar between the 
control and BDNF groups, with increased GAP43 protein 
mRNA expression in the control group at this phase. They 
attributed these findings to the fact that the neurotrophic 
factor stimulated group is at a more “advanced” regene-
ration step in which GAP43 protein expression is already 
lower. Similarly, we might suggest that the regeneration 
process in the cAMP 28D group was in a more advanced 
phase, suggesting a stage beyond sprouting, while the 
CTRL 28D group probably was in an earlier phase in whi-
ch fiber numbers, rather than efficiency, were increasing; 
functionally, both groups had similar behavioral results.
Unfortunately our paradigm is limited and does not 
allow us to reject or accept any of these hypotheses. Diffe-
rent methods, such as more prolonged exposure to cAMP, 
direct and/or systemic availability to the central nuclei 
of the facial nerve, histological analyses with other time 
periods (such as the 21st day and after the 28th day), and 
methods for quantifying myelination and fiber diameter, 
are suggested as continuation for this study.
CONCLUSION
We consider having found behavioral and histome-
tric evidence of a neurotrophic role for cAMP on facial 
nerve regeneration in rats undergoing full nerve transection 
and suture.
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